drugset / Trial / NCT03038919

Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness

NCT03038919

Phase 2/3 Unknown 30 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupOpen-labelTreatment

Summary

The researchers intend to investigate possible anabolic effects of bi-weekly exogenous testosterone administration during intensive care unit (ICU) stay for up to 8 weeks. Control group will receive standard ICU management and will also be followed during ICU stay.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Cypionate Small molecule 200 mg Intramuscular